Rare tumors II: Adrenocortical tumors, neuroendocrine tumors of the appendix, pheochromocytoma and paraganglioma, pancreatoblastoma and solid pseudopapillary tumors of the pancreas.
pediatric oncology
rare tumors
surgery
Journal
Pediatric blood & cancer
ISSN: 1545-5017
Titre abrégé: Pediatr Blood Cancer
Pays: United States
ID NLM: 101186624
Informations de publication
Date de publication:
21 Jul 2024
21 Jul 2024
Historique:
revised:
28
06
2024
received:
25
05
2024
accepted:
02
07
2024
medline:
22
7
2024
pubmed:
22
7
2024
entrez:
22
7
2024
Statut:
aheadofprint
Résumé
Very rare tumors are usually divided into two groups: One includes tumors that are rare among both children and adults; the other one encompasses tumors that frequently occur in adults but are rarely observed in children. In this review, we focus on adrenocortical tumors, neuroendocrine tumors of the appendix, pheochromocytoma and paraganglioma, pancreatoblastoma and solid pseudopapillary tumors of the pancreas, with special attention to the role of surgery as main curative intervention or as part of the multimodal treatment.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e31207Subventions
Organisme : St. Jude Children's Research Hospital
Informations de copyright
© 2024 Wiley Periodicals LLC.
Références
Ferrari A, Brecht IB, Gatta G, et al. Defining and listing very rare cancers of paediatric age: consensus of the Joint Action on Rare Cancers in cooperation with the European Cooperative Study Group for Pediatric Rare Tumors. Eur J Cancer. 2019;110:120‐126.
Ferrari A, Schneider DT, Bisogno G, et al. Facing the challenges of very rare tumors of pediatric age: the European Cooperative Study Group for Pediatric Rare Tumors (EXPeRT) background, goals, and achievements. Pediatr Blood Cancer. 2021;68(4):e28993.
Ferrari A, Casanova M, Massimino M, Sultan I. Peculiar features and tailored management of adult cancers occurring in pediatric age. Expert Rev Anticancer Ther. 2010;10(11):1837‐1851.
Ribeiro RC, Figueiredo B. Childhood adrenocortical tumours. Eur J Cancer. 2004;40(8):1117‐1126.
Gulack BC, Rialon KL, Englum BR, et al. Factors associated with survival in pediatric adrenocortical carcinoma: an analysis of the National Cancer Data Base (NCDB). J Pediatr Surg. 2016;51(1):172‐177.
Rodriguez‐Galindo C, Figueiredo BC, Zambetti GP, Ribeiro RC. Biology, clinical characteristics, and management of adrenocortical tumors in children. Pediatr Blood Cancer. 2005;45(3):265‐273.
Figueiredo BC, Stratakis CA, Sandrini R, et al. Comparative genomic hybridization analysis of adrenocortical tumors of childhood. J Clin Endocrinol Metab. 1999;84(3):1116‐1121.
Wieneke JA, Thompson LDR, Heffess CS. Adrenal cortical neoplasms in the pediatric population: a clinicopathologic and immunophenotypic analysis of 83 patients. Am J Surg Pathol. 2003;27(7):867‐881.
Picard C, Orbach D, Carton M, et al. Revisiting the role of the pathological grading in pediatric adrenal cortical tumours: results from a national cohort study with pathological review. Mod Pathol. 2019;32(4):546‐559.
Lopez‐Nunez O, Virgone C, Kletskaya IS, et al. Diagnostic utility of a modified reticulin algorithm in pediatric adrenocortical neoplasms. Am J Surg Pathol. 2024;48(3):309‐316.
Kuhlen M, Kunstreich M, Wudy SA, et al. Outcome for pediatric adreno‐cortical tumors is best predicted by the COG stage and five‐item microscopic score—report from the German MET studies. Cancers (Basel). 2022;15(1):225.
Rodriguez‐Galindo C, Krailo MD, Pinto EM, et al. Treatment of pediatric adrenocortical carcinoma with surgery, retroperitoneal lymph node dissection, and chemotherapy: the Children's Oncology Group ARAR0332 protocol. J Clin Oncol. 2021;39(22):2463‐2473.
Cecchetto G, Ganarin A, Bien E, et al. Outcome and prognostic factors in high‐risk childhood adrenocortical carcinomas: a report from the European Cooperative Study Group of Pediatric Rare Tumors (EXPeRT). Pediatr Blood Cancer. 2017;64(6):e26368.
Zambaiti E, Duci M, De Corti F, et al. Clinical prognostic factors in pediatric adrenocortical tumors: a meta‐analysis. Pediatr Blood Cancer. 2021;68(3):e28836.
Virgone C, Roganovic J, Vorwerk P, et al. Adrenocortical tumours in children and adolescents: the EXPeRT/PARTNER diagnostic and therapeutic recommendations. Pediatr Blood Cancer. 2021;68(4):e29025.
Kuhlen M, Mier P, Kunstreich M, et al. Locally advanced adrenocortical carcinoma in children and adolescents‐enigmatic and challenging cases. Cancers (Basel). 2023;15(17):4296.
Michalkiewicz E, Sandrini R, Figueiredo B, et al. Clinical and outcome characteristics of children with adrenocortical tumors: a report from the International Pediatric Adrenocortical Tumor Registry. J Clin Oncol. 2004;22(5):838‐845.
Sandrini R, Ribeiro RC, DeLacerda L. Childhood adrenocortical tumors. J Clin Endocrinol Metab. 1997;82(7):2027‐2031.
Cundy TP, Marcus HJ, Clark J, et al. Robot‐assisted minimally invasive surgery for pediatric solid tumours: a systematic review of feasibility and current status. Eur J Pediatr Surg. 2014;24(2):127‐135.
Fascetti‐Leon F, Scotton G, Pio L, et al. Minimally invasive resection of adrenal masses in infants and children: results of a European multi‐center survey. Surg Endosc. 2017;31(11):4505‐4512.
Heloury Y, Muthucumaru M, Panabokke G, Cheng W, Kimber C, Leclair MD. Minimally invasive adrenalectomy in children. J Pediatr Surg. 2012;47(2):415‐421.
Meignan P, Ballouhey Q, Lejeune J, et al. Robotic‐assisted laparoscopic surgery for pediatric tumours: a bicenter experience. J Robot Surg. 2018;12(3):501‐508.
Crucitti F, Bellantone R, Ferrante A, Boscherini M, Crucitti P. The Italian Registry for Adrenal Cortical Carcinoma: analysis of a multiinstitutional series of 129 patients. The ACC Italian Registry Study Group. Surgery. 1996;119(2):161‐170.
Lee JE, Berger DH, el‐Naggar AK, et al. Surgical management, DNA content, and patient survival in adrenal cortical carcinoma. Surgery. 1995;118(6):1090‐1098.
Hedican SP, Marshall FF. Adrenocortical carcinoma with intracaval extension. J Urol. 1997;158(6):2056‐2061.
Kendrick ML, Lloyd R, Erickson L, et al. Adrenocortical carcinoma: surgical progress or status quo? Arch Surg. 2001;136(5):543‐549.
Volante M, Grillo F, Massa F, et al. Neuroendocrine neoplasms of the appendix, colon and rectum. Pathologica. 2021;113(1):19‐27.
Zeineddin S, Aldrink JH, Bering J, et al. Multi‐institutional assessment of the prevalence of neuroendocrine tumors in children undergoing laparoscopic appendectomy for acute appendicitis in the United States. Pediatr Blood Cancer. 2023;70(11):e30620.
Anastasiadis K, Kepertis C, Lampropoulos V, Tsioulas P, Spyridakis I. Carcinoid tumors of the appendix—last decade experience. J Clin of Diagn Res. 2014;8(11):NC01‐NC02.
Vandevelde A, Gera P. Carcinoid tumours of the appendix in children having appendicectomies at Princess Margaret Hospital since 1995. J Pediatr Surg. 2015;50(9):1595‐1599.
Lobeck IN, Jeste N, Geller J, Pressey J, von Allmen D. Surgical management and surveillance of pediatric appendiceal carcinoid tumor. J Pediatr Surg. 2017;52(6):925‐927.
Njere I, Smith LL, Thurairasa D, et al. Systematic review and meta‐analysis of appendiceal carcinoid tumors in children. Pediatr Blood Cancer. 2018;65(8):e27069.
Kaltsas G, Walter T, Knigge U, et al. European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for appendiceal neuroendocrine tumours (aNET). J Neuroendocrinol. 2023;35(10):e13332.
Panek M, Szymczak M, Stepaniuk M, et al. Radical surgical treatment of neuroendocrine tumors of the appendix in children—a Polish multicenter study. Arch Med Sci. 2021;17(4):1128‐1131.
Duess JW, Lange A, Zeidler J, et al. Appendiceal carcinoids in children—prevalence, treatment and outcome in a large nationwide pediatric cohort. Medicina (Kaunas). 2022;59(1):80.
de Lambert G, Lardy H, Martelli H, Orbach D, Gauthier F, Guérin F. Surgical management of neuroendocrine tumors of the appendix in children and adolescents: a retrospective French multicenter study of 114 cases. Pediatr Blood Cancer. 2016;63(4):598‐603.
Virgone C, Cecchetto G, Alaggio R, et al. Appendiceal neuroendocrine tumours in childhood: Italian TREP project. J Pediatr Gastroenterol Nutr. 2014;58(3):333‐338.
Kuhlen M, Kunstreich M, Pape UF, et al. Lymph node metastases are more frequent in paediatric appendiceal NET ≥1.5 cm but without impact on outcome—Data from the German MET studies. Eur J Surg Oncol. 2024;50(4):108051.
Nesti C, Bräutigam K, Benavent M, et al. Hemicolectomy versus appendectomy for patients with appendiceal neuroendocrine tumours 1–2 cm in size: a retrospective, Europe‐wide, pooled cohort study. Lancet Oncol. 2023;24:187‐194.
Pawa N, Clift AK, Osmani H, et al. Surgical management of patients with neuroendocrine neoplasms of the appendix: appendectomy or more. Neuroendocrinology. 2018;106:242‐251.
Boudreaux JP, Klimstra DS, Hassan MM, et al. The NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: well‐differentiated neuroendocrine tumors of the jejunum, ileum, appendix, and cecum. Pancreas. 2010;39(6):753‐766.
Hoegerle S, Nitzsche EU, Stumpf A, et al. Incidental appendix carcinoid. Value of somatostatin receptor imaging. Clin Nucl Med. 1997;22(7):467‐469.
Boxberger N, Redlich A, Böger C, et al. Neuroendocrine tumors of the appendix in children and adolescents. Pediatr Blood Cancer. 2013;60(1):65‐70.
Muth A, Crona J, Gimm O, et al. Genetic testing and surveillance guidelines in hereditary pheochromocytoma and paraganglioma. J Intern Med. 2019;285(2):187‐204.
Babic B, Patel D, Aufforth R, et al. Pediatric patients with PPGL should have routine preoperative genetic testing for common susceptibility genes in addition to imaging to detect extra‐adrenal and metastatic tumours. Surgery. 2017;161(1):220‐227.
Ciftci AO, Tanyel FC, Senocak ME, et al. Pheochromocytoma in children. J Pediatr Surg. 2001;36(3):447‐452.
Lenders JW, Eisenhofer G, Mannelli M, et al. Phaeochromocytoma. Lancet. 2005;366(9486):665‐675.
Lenders JW, Duh QY, Eisenhofer G, et al. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014;99(6):1915‐1942.
Fassnacht M, Assie G, Baudin E, et al. Adrenocortical carcinoma and malignant phaeochromocytoma: ESMO‐EURA‐CAN Clinical Practice Guidelines for diagnosis, treatment and follow‐up. Ann Oncol. 2020;31(11):1476‐1490.
Rednam SP, Erez A, Druker H, et al. Von Hippel‐Lindau and hereditary pheochromocytoma/paraganglioma syndromes: clinical features, genetics, and surveillance recommendations in childhood. Clin Cancer Res. 2017;23(12):e68‐e75.
Jimenez C, Ma J, Roman Gonzalez A, et al. TNM staging and overall survival in patients with PPGL. J Clin Endocrinol Metab. 2023;108:1132‐1142.
Kim HJ, Kim MJ, Kong SH, et al. Characteristics of germline mutations in Korean patients with pheochromocytoma/paraganglioma. J Med Genet. 2022;59(1):56‐64.
Thompson LDR. Pheochromocytoma of the adrenal gland scaled score (PASS) to separate benign from malignant neoplasms: a clinicopathologic and immunophenotypic study of 100 cases. Am J Surg Pathol. 2002;26(5):551‐566.
Pham TH, Moir C, Thompson GB, et al. Pheochromocytoma and paraganglioma in children: a review of medical and surgical management at a tertiary care centre. Pediatrics. 2006;118(3):1109‐1117.
Fishbein L, Del Rivero J, Else T, et al. The North American Neuroendocrine Tumor Society consensus guidelines for surveillance and management of metastatic and/or unresectable pheochromocytoma and paraganglioma. Pancreas. 2021;50(4):469‐493.
Timmers HJLM, Taïeb D, Pacak K, Lenders JWM. Imaging of pheochromocytomas and paragangliomas. Endocr Rev. 2024;45(3):414‐434.
Seamon ML, Yamaguchi I. Hypertension in pheochromocytoma and paraganglioma: evaluation and management in pediatric patients. Curr Hypertens Rep. 2021;23(5):32.
Nazari MA, Jha A, Kuo MJM, et al. Paediatric phaeochromocytoma and paraganglioma: a clinical update. Clin Endocrinol (Oxf). 2023. doi:10.1111/cen.14955
Amodru V, Taieb D, Guerin C, et al. MEN2‐related pheochromocytoma: current state of knowledge, specific characteristics in MEN2B, and perspectives. Endocrine. 2020;69(3):496‐503.
Ein SH, Weitzman S, Thorner P, et al. Pediatric malignant pheochromocytoma. J Pediatr Surg. 1994;29(9):1197‐1201.
Mcbride JF, Atwell TD, Charboneau WJ, et al. Minimally invasive treatment of metastatic pheochromocytoma and paraganglioma: efficacy and safety of radiofrequency ablation and cryoablation therapy. J Vasc Interv Radiol. 2011;22(9):1263‐1270.
Kuo MJM, Nazari MA, Jha A, Pacak K. Pediatric metastatic pheochromocytoma and paraganglioma: clinical presentation and diagnosis, genetics, and therapeutic approaches. Front Endocrinol (Lausanne). 2022;13:936178.
Matthyssens LE, Nuchtern JG, Van De Ven CP, et al. A novel standard for systematic reporting of neuroblastoma surgery: the International Neuroblastoma Surgical Report Form (INSRF): a joint initiative by the pediatric oncological cooperative groups SIOPEN, COG and GPOH. Ann Surg. 2022;275(3):e575‐e585.
Bien E, Godzinski J, Dall'Igna P. Pancreatoblastoma: a report from the European cooperative study group for paediatric rare tumours (EXPeRT). Eur J Cancer. 2011;47:2347‐2352.
Chisholm KM, Hsu CH, Kim MJJ, Rangaswami A, Gray Hazard FK. Congenital pancreatoblastoma: report of an atypical case and review of the literature. J Pediatr Hematol Oncol. 2012;34:310‐315.
Liu T, Zhao T, Shi C, Chen L. Pancreatoblastoma in children: clinical management and literature review. Transl Oncol. 2022;18:101359.
Dall'Igna P, Cecchetto G, Bisogno G, et al. Pancreatic tumors in children and adolescents: the Italian TREP project experience. Pediatr Blood Cancer. 2010;54:675‐680.
Dhebri AR, Connor S, Campbell F, et al. Diagnosis, treatment and outcome of pancreatoblastoma. Pancreatology. 2004;4:441‐453.
Qi X, Zhou B, Liang F, Wang X. Prognostic factors of pancreatic tumors in children and adolescents: a population study based on the surveillance, epidemiology, and end results database. BMC Gastroenterol. 2024;24(1):108.
Bien E, Roganovic J, Krawczyk MA, et al. Pancreatoblastoma in children: EXPeRT/PARTNER diagnostic and therapeutic recommendations. Pediatr Blood Cancer. 2021;68:e29112.
Ogawa T, Okinaga K, Obana K, et al. Pancreatoblastoma treated by delayed operation after effective chemotherapy. J Pediatr Surg. 2000;35:1663‐1665.
Borghi E, Tognon C, Marchini A, Virgone C, Cillo U, Gamba P. Videolaparoscopic microwave ablation: an innovative technique to treat pancreatoblastoma liver metastases in children. J Pediatr Surg Case Rep. 2021;69:101876.
Zheng J, Zhang H, Sun Y, Sun B. CT‐guided radiofrequency ablation following high‐dose chemotherapy of a liver‐metastasizing pancreatoblastoma with tumor thrombus in the portal vein. Pediatr Radiol. 2013;43(10):1391‐1395.
Reggiani G, Affinita MC, Dall'Igna P, Virgone C, Sorbara S, Bisogno G. Treatment strategies for children with relapsed pancreatoblastoma: a literature review. J Pediatr Hematol Oncol. 2021;43(8):288‐293.
Eklund MJ, States LJ, Acord MR, et al. Imaging of pediatric pancreas tumors: a COG Diagnostic Imaging Committee/SPR Oncology Committee White Paper. Pediatr Blood Cancer. 2023;70(4):e29975.
Défachelles AS, Martin De Lassalle E, Boutard P, Nelken B, Schneider P, Patte C. Pancreatoblastoma in childhood: clinical course and therapeutic management of seven patients. Med Pediatr Oncol. 2001;37:47‐52.
Huang Y, Yang W, Hu J, et al. Diagnosis and treatment of pancreatoblastoma in children: a retrospective study in a single pediatric center. Pediatr Surg Int. 2019;35:1231‐1238.
Xu C, Zhong L, Wang Y, et al. Clinical analysis of childhood pancreatoblastoma arising from the tail of the pancreas. J Pediatr Hematol Oncol. 2012;34:e177‐e181.
Namgoong J‐M, Hwang S, Oh SH, et al. Living donor liver transplantation with total pancreatectomy and portal vein homograft replacement in a pediatric patient with advanced pancreatoblastoma. Ann Hepatobiliary Pancreat Surg. 2020;24:78.
Yonekura T, Kosumi T, Hokim M, Hirooka S, Kitayama H, Kubota A. Aggressive surgical and chemotherapeutic treatment of advanced pancreatoblastoma associated with tumor thrombus in portal vein. J Pediatr Surg. 2006;41:596‐598.
Nasher O, Hall NJ, Sebire NJ, De Coppi P, Pierro A. Pancreatic tumours in children: diagnosis, treatment and outcome. Pediatr Surg Int. 2015;31:831‐835.
Blanc T, Meignan P, Vinit N, et al. Robotic surgery in pediatric oncology: lessons learned from the first 100 tumors—a nationwide experience. Ann Surg Oncol. 2022;29:1315‐1326.
Lalli R, Merritt N, Schlachta CM, Bütter A. Robotic‐assisted, spleen‐preserving distal pancreatectomy for a solid pseudopapillary tumour in a pediatric patient: a case report and review of the literature. J Robotic Surg. 2019;13:325‐329.
Reggiani G, Affinita MC, Dall'Igna P, Virgone C, Sorbara S, Bisogno G. Treatment strategies for children with relapsed pancreatoblastoma: a literature review. J Pediatr Hematol Oncol. 2021;43(8):288‐293.
Shorter NA, Glick RD, Klimstra DS, Brennan MF, Laquaglia MP. Malignant pancreatic tumors in childhood and adolescence: the Memorial Sloan‐Kettering experience, 1967 to present. J Pediatr Surg. 2002;37(6):887‐892.
Bolasco G, Capriati T, Grimaldi C, et al. Long‐term outcome of pancreatic function following oncological surgery in children: institutional experience and review of the literature. World J Clin Cases. 2021;9(25):7340‐7349.
Dall'Igna P, Cecchetto G, Bisogno G, et al. Pancreatic tumors in children and adolescents: the Italian TREP project experience. Pediatr Blood Cancer. 2010;54(5):675‐680.
Wu J, Mao Y, Jiang Y, et al. Sex differences in solid pseudopapillary neoplasm of the pancreas: a population‐based study. Cancer Med. 2020;9(16):6030‐6041.
Basturk O, Hong SM, Wood LD, et al. A revised classification system and recommendations from the Baltimore Consensus Meeting for Neoplastic Precursor Lesions in the Pancreas. Am J Surg Pathol. 2015;39:1730‐1741.
Crocoli A, Grimaldi C, Virgone C, et al. Outcome after surgery for solid psudopapillary pancreatic tumors in children: report from the TREP project—Rare Tumors Study Group. Pediatr Blood Cancer. 2018;66:e27519.
Irtan S, Galmiche‐Rolland L, Elie C, et al. Recurrence of solid pseudopapillary neoplasms of the pancreas: results of a nationwide study of risk factors and treatment modalities. Pediatr Blood Cancer. 2016;63:1515‐1521.
Jentzsch C, Fuchs J, Agaimy A, et al. Solid pseudopapillary neoplasms of the pancreas in childhood and adolescence‐an analysis of the German Registry for Rare Pediatric Tumors (STEP). Eur J Pediatr. 2023;182(12):5341‐5352.
Rojas Y, Warneke CL, Dhamne CA, et al. Primary malignant pancreatic neoplasms in children and adolescents: a 20‐year experience. J Pediatr Surg. 2012;47:2199‐2204.
Brierley J, Gospodarowicz M, Wittekind C. TNM Classification of Malignant Tumours. 8th ed. Wiley‐Blackwell; 2016:272.
Hwang J, Kim DY, Kim SC, Namgoong JM, Hong SM. Solid‐pseudopapillary neoplasm of the pancreas in children: can we predict malignancy? J Pediatr Surg. 2014;49(12):1730‐1733.
Shimizu M, Matsumoto T, Hirokawa M, et al. Solid pseudopapillary carcinoma of the pancreas. Pathol Int. 1999;49(3):231‐234.
Radulovic MK, Brecelj J, Gruden A, Flezar MS. Role of endoscopic ultrasound‐guided fine needle aspiration biopsies in diagnosing pancreatic neoplasms in the paediatric population: experience from a tertiary center and review of the literature. Radiol Oncol. 2024;58(1):78‐86.
Yamabe A, Irisawa A, Bhutani MS, et al. Efforts to improve the diagnostic accuracy of endoscopic ultrasound‐guided fine‐needle aspiration for pancreatic tumors. Endosc Ultrasound. 2016;5:225‐232.
Mansfield SA, Mahida JB, Dillhoff M, et al. Pancreaticoduodenectomy outcomes in the pediatric, adolescent, and young adult population. J Surg Res. 2016;204:232‐236.
Dasgupta R, Kim PC. Relationship between surgical volume and clinical outcome: should pediatric surgeons be doing pancreaticoduodenectomies? J Pediatr Surg. 2005;40:793‐796.
Sokolov YY, Stonogin SV, Donskoy DV, Povarnin OY, Vilesov AV. Laparoscopic pancreatic resections for solid pseudopapillary tumor in children. Eur J Pediatr Surg. 2009;19:399‐401.
Namgoong JM, Kim DY, Kim SC, Hwang JH, Song KB. Laparoscopic distal pancreatectomy to treat solid pseudopapillary tumors in children: transition from open to laparoscopic approaches in suitable cases. Pediatr Surg Int. 2014;30:259‐266.
Schultz KAP, Chintagumpala M, Piao J, et al. Children's Oncology Group's 2023 blueprint for research: rare tumors. Pediatr Blood Cancer. 2023;70(6):e30574.